LEE PAVEL: Open Payments
NPI 1831487107 · BONITA SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,953 in 76 payments from 36 companies in 2025. Trend: 2023 $138 · 2024 $292 · 2025 $1,953
Food & beverage: $1,953
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $225 |
| Janssen Biotech, Inc. | 4 | $212 |
| BeOne Medicines USA, Inc. | 7 | $188 |
| Celgene Corporation | 4 | $134 |
| Incyte Corporation | 6 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| GlaxoSmithKline, LLC. | 3 | $79 |
| Azurity Pharmaceuticals, Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Janssen Scientific Affairs, LLC | 1 | $45 |
Products named: RYBREVANT, BRUKINSA, REBLOZYL, ENHERTU, OJJAARA, JAKAFI, DANZITEN, PLUVICTO.
Industry payments across FL — which companies pay providers there.
